RKLB

Over the past six months (March 2026 - September 2026), positive stock impacts included Cathie Wood's ARK funds acquiring 681,000 RKLB shares, a successful 94th Electron launch, a long-term contract with Synspective, the announcement of new IMM Apex germanium-free solar cells, a 3% stock increase on September 22, 2026, and the successful 96th Electron mission. Rocket Lab fully funded its Iridium acquisition with a $1.94 billion ATM offering, reported record Q2 2026 revenue of $234 million (62% YoY increase) and a record backlog of $2.36 billion (137% YoY increase), and secured a $397 million Space Force contract. Analysts generally maintain a 'Moderate Buy' consensus rating with an average price target of $107.32, with several firms initiating or maintaining positive ratings. Negative impacts included delays in the Neutron rocket's development, pushing its first flight into 2027, which is a concern given the company's lack of profitability and $84.1 million operating cash burn in Q2 2026. The issuance of approximately $1.9 billion in new stock for the Iridium acquisition resulted in significant shareholder dilution. Insider selling activity included the CFO selling 140,000 shares and CEO Peter Beck selling 3.28 million shares. Q2 2026 earnings reported an EPS of ($0.08), missing consensus estimates, and some analysts downgraded or initiated neutral ratings.